The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Lupin and its alliance partner Natco received clearance from the FDA for bosentan tablets for oral suspension, 32 mg, which ...

Previously only available at Walmart, the line is available at 1,400 CVS Pharmacy locations and on the retailer’s website ...

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

Tennessee Attorney General Jonathan Skrmetti is leading a bipartisan coalition urging the Food and Drug Administration to ...

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A lawsuit filed in the Singapore International Commercial Court is seeking $830 million in damages from KBP, with Novo ...

Potential serious side effects for Ozempic and Wegovy include possible thyroid tumors, including cancer; pancreatitis, vision changes, low blood sugar, kidney failure, gallbladder problems and ...

"This isn't sci-fi. It's just we aren't there yet." -- Adam Rodman, MD, MPH, director of artificial intelligence (AI) programs at Beth Israel Deaconess Medical Center in Boston, discussing a new bill ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...